CPT code 84152 denotes the laboratory assay for complexed prostate specific antigen (cPSA), a blood-based marker produced by the prostate and commonly used in the clinical evaluation related to prostate cancer. Nationally, cPSA testing contributes to diagnostic workflows, risk stratification, and monitoring strategies in urology and oncology, and its billing impacts laboratory utilization and payer coverage policies.

Key payers addressed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of clinical context for cPSA testing, the typical service environment (clinical and hospital laboratories), and the practical billing considerations tied to CPT code 84152.

This publication provides benchmarks and payer coverage patterns where available, summarizes relevant policy developments affecting laboratory test reimbursement, and outlines common clinical indications and testing workflows for cPSA. The content is intended to help coding professionals, laboratory managers, and policy analysts understand how CPT code 84152 fits into national laboratory billing and clinical practice. Data not available in the input for detailed payer-specific rates, ICD-10 mappings, and related codes.